Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$100.73 - $112.44 $21,959 - $24,511
218 Added 23.12%
1,161 $120,000
Q1 2024

Jul 17, 2024

BUY
$109.52 - $120.96 $11,718 - $12,942
107 Added 12.8%
943 $107,000
Q4 2023

Jul 17, 2024

BUY
$90.19 - $110.4 $12,446 - $15,235
138 Added 19.77%
836 $92 Million
Q3 2023

Jul 17, 2024

SELL
$95.53 - $114.62 $3,630 - $4,355
-38 Reduced 5.16%
698 $67.6 Million
Q2 2023

Jul 17, 2024

BUY
$100.78 - $112.29 $14,411 - $16,057
143 Added 24.11%
736 $80.2 Million
Q1 2023

Jul 17, 2024

BUY
$96.86 - $114.01 $5,714 - $6,726
59 Added 11.05%
593 $60 Million
Q4 2022

Jul 17, 2024

BUY
$95.06 - $111.52 $190 - $223
2 Added 0.38%
534 $58.6 Million
Q3 2022

Jul 17, 2024

BUY
$96.76 - $112.03 $96 - $112
1 Added 0.19%
532 $51.5 Million
Q2 2022

Jul 17, 2024

BUY
$102.07 - $123.37 $102 - $123
1 Added 0.19%
531 $57.7 Million
Q1 2022

Jul 17, 2024

SELL
$114.02 - $139.04 $11,287 - $13,764
-99 Reduced 15.74%
530 $62.7 Million
Q4 2021

Jul 17, 2024

BUY
$115.53 - $141.46 $115 - $141
1 Added 0.16%
629 $88.5 Million
Q3 2021

Jul 17, 2024

SELL
$116.66 - $129.06 $8.41 Million - $9.3 Million
-72,083 Reduced 99.14%
628 $74.2 Million
Q2 2021

Jul 17, 2024

BUY
$105.79 - $124.53 $7.63 Million - $8.98 Million
72,128 Added 12371.87%
72,711 $627,000
Q1 2021

Jul 17, 2024

BUY
$108.84 - $128.23 $108 - $128
1 Added 0.17%
583 $69.9 Million
Q4 2020

Jul 17, 2024

SELL
$105.0 - $114.42 $2,100 - $2,288
-20 Reduced 3.32%
582 $63.7 Million
Q3 2020

Jul 17, 2024

BUY
$91.64 - $111.29 $91 - $111
1 Added 0.17%
602 $65.6 Million
Q2 2020

Jul 17, 2024

BUY
$76.57 - $98.0 $3,139 - $4,018
41 Added 7.32%
601 $55 Million
Q1 2020

Jul 17, 2024

BUY
$62.82 - $91.86 $6,156 - $9,002
98 Added 21.21%
560 $44.2 Million
Q2 2019

Jul 17, 2024

BUY
$72.88 - $85.0 $72 - $85
1 Added 0.22%
462 $38.8 Million
Q1 2019

Jul 17, 2024

BUY
$66.22 - $80.06 $30,527 - $36,907
461 New
461 $36.9 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Kelly Financial Services LLC Portfolio

Follow Kelly Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.